GENERAL MANAGER - SOUTH AMERICA, HOFMANN ENGINEERING
"We are constantly looking at what are the current performances and failure modes of the OEM product and with our own design department, we carry out investigations and engineering analysis to come up with better features to improve our products."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.